The Role of Rilpivirine in Clinical Practice: Strengths and Weaknesses of the New Nonnucleoside Reverse Transcriptase Inhibitor for HIV Therapy
Time to HIV-1 RNA Suppression Below 5 copies/ml During First-Line Protease Inhibitor-Based Antiretroviral Treatment – Any Impact of Residual Viremia on Treatment Success?
Stribild® (Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate): A New Paradigm for HIV-1 Treatment
Measurement of HIV-1 Viral Load for Drug Resistance Surveillance using Dried Blood Spots: Literature Review and Modeling of Contribution of DNA and RNA